• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evofem Biosciences, Inc. - Common Stock (NQ:EVFM)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evofem Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
EVFM Stock Earnings: Evofem Biosciences Reported Results for Q1 2024 ↗
May 15, 2024
Evofem Biosciences just reported results for the first quarter of 2024. 
Via InvestorPlace
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Merger Target Expects ‘Fourth Consecutive Year of Net Sales Growth’
May 15, 2024
Via Investor Brand Network
News headline image
EVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023 ↗
March 27, 2024
Evofem Biosciences just reported results for the fourth quarter of 2023. 
Via InvestorPlace
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Acquisition Target Reports Increased Product Sales, Ongoing Revenue Growth
March 27, 2024
Via Investor Brand Network
News headline image
Why Is Evofem (EVFM) Stock Up 85% Today? ↗
December 12, 2023
Here's one under-the-radar penny stock that investors are buying up big today. But the question is, why is EVFM stock surging? 
Via InvestorPlace
Evofem Biosciences's Return On Capital Employed Insights ↗
January 09, 2023
 
Via Benzinga
News headline image
Evofem Biosciences Return On Capital Employed Overview ↗
August 18, 2022
  
Via Benzinga
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Potential Acquisition Releases FY 2023 Preliminary Financial Report
February 01, 2024
Via Investor Brand Network
News headline image
EVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFM
December 18, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk Shipping Inc. (NYSE - EGLE), Icosavax, Inc. (Nasdaq - ICVX), Evofem Biosciences, Inc. (OTC - EVFM), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
December 18, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Definitive Agreement to Acquire Evofem Biosciences Inc.
December 12, 2023
Via Investor Brand Network
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eagle Bulk Shipping Inc. (NYSE - EGLE), Icosavax, Inc. (Nasdaq - ICVX), Evofem Biosciences, Inc. (OTC - EVFM), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
December 12, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Why Is Life Sciences-Focused Aditxt Stock Trading Higher Today? ↗
December 12, 2023
Aditxt Inc (NASDAQ: ADTX) has agreed to acquire Evofem Biosciences Inc (OTC: EVFM) in consideration of the issuance of a combination of common stock and preferred stock and the assumption of certain... 
Via Benzinga
News headline image
EVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to Shareholders
December 12, 2023
From Halper Sadeh LLC
Via Business Wire
News headline image
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi®, the First and Only FDA-Approved Hormone-Free Contraceptive Gel, to Address Diverse Reproductive Health Needs of Women Globally
December 12, 2023
From Aditxt, Inc.
Via Business Wire
News headline image
CapitalGainsReport: Thursday’s OTC Watchlist (EVFM, EPAZ, NWBO, VDRM)
March 23, 2023
CapitalGainsReport: Thursday’s OTC Watchlist (EVFM, EPAZ, NWBO, VDRM) 
Via News Direct
News headline image
Evofem Biosciences Inc. (OTC:EVFM): Here Are Latest News & Updates
March 01, 2023
Evofem Biosciences Inc. (OTC:EVFM): Here Are Latest News & Updates 
Via News Direct
News headline image
OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes ↗
December 13, 2022
The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 5.56% in November, recording two subsequent monthly increases for the first time in 2022. 
Via Benzinga
News headline image
Why Evofem Biosciences Shares Are Plunging Today? ↗
October 12, 2022
Evofem Biosciences Inc's (OTC: EVFM) recently completed the Phase 3 EVOGUARD trial evaluating Phexxi vaginal gel (EVO100) to prevent chlamydia and gonorrhea infection in women but did not achieve its... 
Via Benzinga
News headline image
4 Analysts Have This to Say About Evofem Biosciences ↗
August 15, 2022
  Over the past 3 months, 4 analysts have published their opinion on Evofem Biosciences (OTC:EVFM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗
October 13, 2022
Upgrades 
Via Benzinga
News headline image
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗
August 11, 2022
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
Evofem Biosciences Phase 3 EVOGUARD Trial Puts October Catalyst In Play, Here’s Why Investors Are Paying Attention ($EVFM)
August 10, 2022
Via AB Newswire
News headline image
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
News headline image
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
News headline image
Traders News Source Senior Editor, Mark Roberts Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier
August 09, 2022
Via ACCESSWIRE
Evofem Biosciences Stock Jumps 185% Since June…Here’s Why Its FDA-Approved Phexxi May Add Appreciably To Those Gains In 2/H 2022 ($EVFM)
August 08, 2022
Via AB Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
August 05, 2022
Gainers 
Via Benzinga
News headline image
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗
August 08, 2022
Gainers 
Via Benzinga
News headline image
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session ↗
August 05, 2022
Gainers Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap